Objective: To evaluate the antimalarial and antioxidant properties of stem bark extracts of Haematostaphis barteri(H. barteri).Methods: The prophylactic activity of the plant was performed by dosing mice with sulfadoxine-pyrimethamine(1.2 mg/kg), aqueous extract(30, 100, 300 mg/kg) and dichloromethane/methanol(D/M)(30, 100, 300 mg/kg) extracts of H. barteri for 3 days. On the 4th day, the mice were inoculated with Plasmodium berghei. The parasite density was estimated for each mouse 72 h post-parasite inoculation. The curative activity of the plant was also performed by inoculating mice with Plasmodium berghei. Three days later, they were treated with artemether-lumefantrine(4 mg/kg), aqueous and D/M extracts of H. barteri stem bark for 5 days. The in vitro antioxidant property of the aqueous extract was determined by using the reducing power, nitric oxide and total antioxidant capacity assays. Results: The aqueous extract exerted significant(P < 0.05) curative and prophylactic antimalarial activities. The D/M extract exhibited significant curative(P < 0.05) but not prophylactic antiplasmodial ef ect. The aqueous extract exhibited in vitro antioxidant property with IC50’s of(0.930 ± 0.021) mg/mL,(0.800 ± 0.001) mg/mL and(0.22 ± 0.05) mg/mL in the total antioxidant capacity, reducing power and nitric oxide assays. Histological assessment of the liver of aqueous and D/M treated animals did not reveal any sign of toxicity.Conclusions: H. barteri is not toxic which exerted significant curative antiplasmodial ef ects but the prophylactic property was however fraction dependent. The mechanism of the antiplasmodial activity of H. barteri may partly be mediated by its antioxidant property. Objective: To evaluate the antimalarial and antioxidant properties of stem bark extracts of Haematostaphis barteri (H. barteri). Methods: The prophylactic activity of the plant was performed by dosing mice with sulfadoxine-pyrimethamine (1.2 mg / kg), aqueous extract (30 , 100, 300 mg / kg) and dichloromethane / methanol (D / M) (30, 100, 300 mg / kg) extracts of H. barteri for 3 days. On the 4th day, the mice were inoculated with Plasmodium berghei. The curative activity of the plant was also performed by inoculating mice with Plasmodium berghei. Three days later, they were treated with artemether-lumefantrine (4 mg / kg), aqueous and The in vitro antioxidant property of the aqueous extract was determined by using the reducing power, nitric oxide and total antioxidant capacity assays. Results: The aqueous extract exerted significant (P <0.05 ) curative and prophylactic antimal The aqueous extract of vitro drug extracts of vitro antioxidant properties with IC50’s of (0.930 ± 0.021) mg / mL, (0.800 ± 0.001) mg / mL of arial activities. The D / M extract showed significant curative mL and (0.22 ± 0.05) mg / mL in the total antioxidant capacity, reducing power and nitric oxide assays. Histological assessment of the liver of aqueous and D / M treated animals did not reveal any sign of toxicity. Conclusions: H. barteri is not toxic which exerted significant curative antiplasmodial ef ects but the prophylactic property was fraction-dependent. The mechanism of the antiplasmodial activity of H. barteri may partially be mediated by its antioxidant property.